Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Temporary Codes for Use with Outpatient Prospective Payment System
C9096 is a valid 2024 HCPCS code for Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram or just “Inj, releuko, 1 mcg” for short, used in Medical care.
HCPCS Level II Code Temporary Codes for Use with Outpatient Prospective Payment System |
|
HCPCS Code | C9096 |
---|---|
Description |
Long description:
Short description: |
HCPCS Modifier1 | |
HCPCS Pricing indicator |
53 - Statute
|
Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
Coverage code | C - Carrier judgment |
BETOS2 code | O1E - Other drugs |
HCPCS Action code | N - No maintenance for this code |
Type of service | 1 - Medical care |
Effective date | Effective Oct 01, 2022 |
Date added | Added Jul 01, 2022 |
Termination date | Sep 30, 2022 |
HCPCS Coding Procedures |
In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.
Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
“NU” identifies the hospital bed as new equipment
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”